Etoposide
- Product NDC
- 16729-262
- 11-digit product format
- 167290262
- Labeler code
- 16729
- Product ID
- 16729-262_bb6eeb29-d900-21f6-e053-2a95a90a679e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etoposide
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Accord Healthcare Inc.
- Application
- ANDA074513
- Marketing category
- ANDA
- Marketing start
- 2013-08-22
- Marketing end
- 2021-10-31
- Substance
- ETOPOSIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16729-262-31 | 16729026231 | 1 VIAL, MULTI-DOSE in 1 BOX (16729-262-31) > 5 mL in 1 VIAL, MULTI-DOSE | 2013-08-22 | 2021-10-31 | No | No | Current |